First American Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

First American Bank's REGN Position: Q3 2017 in Review

First American Bank sold out of Regeneron Pharmaceuticals (REGN) in Q3 2017, closing a stake of 674 shares — an estimated $331K sold.

First American Bank first reported a position in REGN in Q4 2016 and held it in 3 quarters. The position peaked at $334K in Q4 2016. 605 funds tracked by Wall St. Rank hold REGN as of Q3 2017.

• First American Bank reported no remaining Regeneron Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
• First American Bank sold 674 Regeneron Pharmaceuticals shares in Q3 2017, an estimated $331K.
• First American Bank first reported a position in Regeneron Pharmaceuticals in Q4 2016 and held it in 3 quarters.
• First American Bank's Regeneron Pharmaceuticals position peaked at $334K in Q4 2016.
• 605 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2017.

Based on First American Bank's 13F filing for Q3 2017, filed 6 Oct 2017.